SYMPOSIA

Bulletin of Clinical Psychopharmacology, Vol: 21, Supplement: 2, 2011 - www.psikofarmakoloji.org
Poster Presentations
post-dose assessment times. There was a trend for dose-related effects on performance of the MTF, in particular for the Stroop task, where
there was an advantage for the 300 mg dose.
Conclusions: This is the first demonstration of acute neurocognitive effects of BM. The combination of increased alertness for 600 mg and
better selective attentional performance for 300 mg suggests that mood and cognitive processes can be dissociated and that different
doses of Bacopa may benefit different neural mechanisms.
Further participants are needed for this cohort to increase the statistical power of these findings.
Key words: Bacopa monnieri, nutraceuticals, mood, cognition
References:
1. Nathan, P.J., et al., The acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjects, in Human Psychopharmacology:
Clinical & Experimental. 2001, John Wiley & Sons Ltd. 1996. p. 345-351.
Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S152-3
[PP-053] Ref. No: 201
Anxiety and depressive symptom levels among adolescents with risk taking behaviour
Nuray Sarp 1 , Aylin Aksoy Çoban 2 , Kültegin Ögel 3
1Acıbadem Fulya Hospital, Psychiatry service, Psychology Department, İstanbul, Turkey
2Acıbadem Fulya Hospital, Psychiatry service, Istanbul, Turkey
3Acıbadem University School of medicine, Department of Mental Heath Disease, Istanbul, Turkey
E-mail: ogelk@ogelk.net
Background: In our country, risk taking behavior has increased among adolescents in recent years. Risky behaviours are defined as
behaviors that affect an adolescent’s health and wellness and daily life directly or indirectly. These behaviours can cause potential
negative results. Bullying, smoking, using alcohol or drugs, early or unprotected sexual activity, skipping school, elopement, damaging
friends and self destruction are the most frequent risky behaviors among adolescents. Through previous research, it has been shown that
the moods of adolescents with risky behaviors differ from other adolescents. Thus it is thought that there may be an association between
risky behavior and depression and anxiety.
Objective: This study investigated the differences between adolescents with risky behaviour and the ones with non-risky behaviour in
terms of depressive and anxiety symptom levels.
Methods: The participants were from different regions and different socio-economic statuses. A total of 3483 students from forty-three
schools (12 vocational high schools, 23 state schools and 6 private high schools ) and104 classes were included in this study. The multistage
cluster sampling method was used for the selection of the sample. In the study, YSR 11-18 (Youth Self Report) and a questionnaire,
which was developed by the researchers, were used. The research survey consisted of 238 items; The questions covered demographical
information, parent and region features, problems about school life, risky behaviours, neglect and abuse, disease, trauma, and health.
Results: In this study, 45.5% of participants were female, 54.5% were male. According to the analysis of each risky behaviour, significant
differences were found for depressive and anxiety symptom levels between groups.
Adolescents who exhibit bullying, elopement, self destruction, commit crimes, and have damaging friends are more likely to show
anxiety and depressive symptoms compared to non-risky behavior adolescents.(p=0.000). In addition, the level of depressive and anxiety
symptoms of drug users were higher than the level of depressive and anxiety symptoms of non-users (depressive; p=0.000, anxiety;
p=0.019).
Adolescents who are carrying a weapon, using alcohol, working in a job and skipping school had a higher level of only depressive
symptoms (p=0.0000). On the other hand, only the high level anxiety group had unprotected sexual activity (p=0.092).
Conclusions: A comparison of non-risky behavior adolescents to risky behavior adolescents showed significant differences in terms of
anxiety and depressive symptom levels and these symptom levels changed according to the risky behaviour type.
Key words: Adolescents, anxiety symptom levels, depressive symmptom levels, risky behavior
Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S153
S153